Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
To assess the efficacy of multiple dupilumab dose-regimens, compared to placebo, in adult participants with moderate-to-severe atopic dermatitis (AD).
Epistemonikos ID: 5f1cff23c19e0914a345d4f2f17ac8c32b5ed372
First added on: May 11, 2024